Pharma & Healthcare
Global Radioactive Diagnostic Drugs Market Research Report 2024
- Feb 19, 24
- ID: 51578
- Pages: 80
- Figures: 170
- Views: 12
The global Radioactive Diagnostic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Radioactive Diagnostic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radioactive Diagnostic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Radioactive Diagnostic Drugs in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Radioactive Diagnostic Drugs include Curium, Medi-Radiopharma, Jubilant Radiopharma, Telix, Mallinckrodt, Cardinal Health, Bayer AG, GE Healthcare and Mallinckrodt Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radioactive Diagnostic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioactive Diagnostic Drugs.
Report Scope
The Radioactive Diagnostic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radioactive Diagnostic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioactive Diagnostic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Curium
Medi-Radiopharma
Jubilant Radiopharma
Telix
Mallinckrodt
Cardinal Health
Bayer AG
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Segment by Type
Single Photon Drugs
Positron Drugs
Blood Perfusion Drugs
Metabolizing Drugs
Receptor Binding Drugs
Others
Segment by Application
Oncology
Cardiology
Neuroscience
Thyroid
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Diagnostic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Radioactive Diagnostic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radioactive Diagnostic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Radioactive Diagnostic Drugs in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Radioactive Diagnostic Drugs include Curium, Medi-Radiopharma, Jubilant Radiopharma, Telix, Mallinckrodt, Cardinal Health, Bayer AG, GE Healthcare and Mallinckrodt Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radioactive Diagnostic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioactive Diagnostic Drugs.
Report Scope
The Radioactive Diagnostic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radioactive Diagnostic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioactive Diagnostic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Curium
Medi-Radiopharma
Jubilant Radiopharma
Telix
Mallinckrodt
Cardinal Health
Bayer AG
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Segment by Type
Single Photon Drugs
Positron Drugs
Blood Perfusion Drugs
Metabolizing Drugs
Receptor Binding Drugs
Others
Segment by Application
Oncology
Cardiology
Neuroscience
Thyroid
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Diagnostic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioactive Diagnostic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Photon Drugs
1.2.3 Positron Drugs
1.2.4 Blood Perfusion Drugs
1.2.5 Metabolizing Drugs
1.2.6 Receptor Binding Drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Radioactive Diagnostic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neuroscience
1.3.5 Thyroid
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioactive Diagnostic Drugs Market Perspective (2019-2030)
2.2 Radioactive Diagnostic Drugs Growth Trends by Region
2.2.1 Global Radioactive Diagnostic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Radioactive Diagnostic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Radioactive Diagnostic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Radioactive Diagnostic Drugs Market Dynamics
2.3.1 Radioactive Diagnostic Drugs Industry Trends
2.3.2 Radioactive Diagnostic Drugs Market Drivers
2.3.3 Radioactive Diagnostic Drugs Market Challenges
2.3.4 Radioactive Diagnostic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioactive Diagnostic Drugs Players by Revenue
3.1.1 Global Top Radioactive Diagnostic Drugs Players by Revenue (2019-2024)
3.1.2 Global Radioactive Diagnostic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Radioactive Diagnostic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioactive Diagnostic Drugs Revenue
3.4 Global Radioactive Diagnostic Drugs Market Concentration Ratio
3.4.1 Global Radioactive Diagnostic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioactive Diagnostic Drugs Revenue in 2023
3.5 Radioactive Diagnostic Drugs Key Players Head office and Area Served
3.6 Key Players Radioactive Diagnostic Drugs Product Solution and Service
3.7 Date of Enter into Radioactive Diagnostic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioactive Diagnostic Drugs Breakdown Data by Type
4.1 Global Radioactive Diagnostic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Radioactive Diagnostic Drugs Forecasted Market Size by Type (2025-2030)
5 Radioactive Diagnostic Drugs Breakdown Data by Application
5.1 Global Radioactive Diagnostic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Radioactive Diagnostic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Radioactive Diagnostic Drugs Market Size (2019-2030)
6.2 North America Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
6.4 North America Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioactive Diagnostic Drugs Market Size (2019-2030)
7.2 Europe Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
7.4 Europe Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioactive Diagnostic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Radioactive Diagnostic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioactive Diagnostic Drugs Market Size (2019-2030)
9.2 Latin America Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
9.4 Latin America Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioactive Diagnostic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Curium
11.1.1 Curium Company Detail
11.1.2 Curium Business Overview
11.1.3 Curium Radioactive Diagnostic Drugs Introduction
11.1.4 Curium Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.1.5 Curium Recent Development
11.2 Medi-Radiopharma
11.2.1 Medi-Radiopharma Company Detail
11.2.2 Medi-Radiopharma Business Overview
11.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Introduction
11.2.4 Medi-Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.2.5 Medi-Radiopharma Recent Development
11.3 Jubilant Radiopharma
11.3.1 Jubilant Radiopharma Company Detail
11.3.2 Jubilant Radiopharma Business Overview
11.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Introduction
11.3.4 Jubilant Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.3.5 Jubilant Radiopharma Recent Development
11.4 Telix
11.4.1 Telix Company Detail
11.4.2 Telix Business Overview
11.4.3 Telix Radioactive Diagnostic Drugs Introduction
11.4.4 Telix Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.4.5 Telix Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Radioactive Diagnostic Drugs Introduction
11.5.4 Mallinckrodt Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.5.5 Mallinckrodt Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Detail
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Radioactive Diagnostic Drugs Introduction
11.6.4 Cardinal Health Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.6.5 Cardinal Health Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Radioactive Diagnostic Drugs Introduction
11.7.4 Bayer AG Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.7.5 Bayer AG Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Radioactive Diagnostic Drugs Introduction
11.8.4 GE Healthcare Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.8.5 GE Healthcare Recent Development
11.9 Mallinckrodt Pharmaceuticals
11.9.1 Mallinckrodt Pharmaceuticals Company Detail
11.9.2 Mallinckrodt Pharmaceuticals Business Overview
11.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Introduction
11.9.4 Mallinckrodt Pharmaceuticals Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.9.5 Mallinckrodt Pharmaceuticals Recent Development
11.10 Bracco Group
11.10.1 Bracco Group Company Detail
11.10.2 Bracco Group Business Overview
11.10.3 Bracco Group Radioactive Diagnostic Drugs Introduction
11.10.4 Bracco Group Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.10.5 Bracco Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioactive Diagnostic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Photon Drugs
1.2.3 Positron Drugs
1.2.4 Blood Perfusion Drugs
1.2.5 Metabolizing Drugs
1.2.6 Receptor Binding Drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Radioactive Diagnostic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neuroscience
1.3.5 Thyroid
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioactive Diagnostic Drugs Market Perspective (2019-2030)
2.2 Radioactive Diagnostic Drugs Growth Trends by Region
2.2.1 Global Radioactive Diagnostic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Radioactive Diagnostic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Radioactive Diagnostic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Radioactive Diagnostic Drugs Market Dynamics
2.3.1 Radioactive Diagnostic Drugs Industry Trends
2.3.2 Radioactive Diagnostic Drugs Market Drivers
2.3.3 Radioactive Diagnostic Drugs Market Challenges
2.3.4 Radioactive Diagnostic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioactive Diagnostic Drugs Players by Revenue
3.1.1 Global Top Radioactive Diagnostic Drugs Players by Revenue (2019-2024)
3.1.2 Global Radioactive Diagnostic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Radioactive Diagnostic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioactive Diagnostic Drugs Revenue
3.4 Global Radioactive Diagnostic Drugs Market Concentration Ratio
3.4.1 Global Radioactive Diagnostic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioactive Diagnostic Drugs Revenue in 2023
3.5 Radioactive Diagnostic Drugs Key Players Head office and Area Served
3.6 Key Players Radioactive Diagnostic Drugs Product Solution and Service
3.7 Date of Enter into Radioactive Diagnostic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioactive Diagnostic Drugs Breakdown Data by Type
4.1 Global Radioactive Diagnostic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Radioactive Diagnostic Drugs Forecasted Market Size by Type (2025-2030)
5 Radioactive Diagnostic Drugs Breakdown Data by Application
5.1 Global Radioactive Diagnostic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Radioactive Diagnostic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Radioactive Diagnostic Drugs Market Size (2019-2030)
6.2 North America Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
6.4 North America Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioactive Diagnostic Drugs Market Size (2019-2030)
7.2 Europe Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
7.4 Europe Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioactive Diagnostic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Radioactive Diagnostic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioactive Diagnostic Drugs Market Size (2019-2030)
9.2 Latin America Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
9.4 Latin America Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioactive Diagnostic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Radioactive Diagnostic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Curium
11.1.1 Curium Company Detail
11.1.2 Curium Business Overview
11.1.3 Curium Radioactive Diagnostic Drugs Introduction
11.1.4 Curium Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.1.5 Curium Recent Development
11.2 Medi-Radiopharma
11.2.1 Medi-Radiopharma Company Detail
11.2.2 Medi-Radiopharma Business Overview
11.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Introduction
11.2.4 Medi-Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.2.5 Medi-Radiopharma Recent Development
11.3 Jubilant Radiopharma
11.3.1 Jubilant Radiopharma Company Detail
11.3.2 Jubilant Radiopharma Business Overview
11.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Introduction
11.3.4 Jubilant Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.3.5 Jubilant Radiopharma Recent Development
11.4 Telix
11.4.1 Telix Company Detail
11.4.2 Telix Business Overview
11.4.3 Telix Radioactive Diagnostic Drugs Introduction
11.4.4 Telix Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.4.5 Telix Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Radioactive Diagnostic Drugs Introduction
11.5.4 Mallinckrodt Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.5.5 Mallinckrodt Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Detail
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Radioactive Diagnostic Drugs Introduction
11.6.4 Cardinal Health Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.6.5 Cardinal Health Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Radioactive Diagnostic Drugs Introduction
11.7.4 Bayer AG Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.7.5 Bayer AG Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Radioactive Diagnostic Drugs Introduction
11.8.4 GE Healthcare Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.8.5 GE Healthcare Recent Development
11.9 Mallinckrodt Pharmaceuticals
11.9.1 Mallinckrodt Pharmaceuticals Company Detail
11.9.2 Mallinckrodt Pharmaceuticals Business Overview
11.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Introduction
11.9.4 Mallinckrodt Pharmaceuticals Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.9.5 Mallinckrodt Pharmaceuticals Recent Development
11.10 Bracco Group
11.10.1 Bracco Group Company Detail
11.10.2 Bracco Group Business Overview
11.10.3 Bracco Group Radioactive Diagnostic Drugs Introduction
11.10.4 Bracco Group Revenue in Radioactive Diagnostic Drugs Business (2019-2024)
11.10.5 Bracco Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Radioactive Diagnostic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Single Photon Drugs
Table 3. Key Players of Positron Drugs
Table 4. Key Players of Blood Perfusion Drugs
Table 5. Key Players of Metabolizing Drugs
Table 6. Key Players of Receptor Binding Drugs
Table 7. Key Players of Others
Table 8. Global Radioactive Diagnostic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Radioactive Diagnostic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Radioactive Diagnostic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Radioactive Diagnostic Drugs Market Share by Region (2019-2024)
Table 12. Global Radioactive Diagnostic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Radioactive Diagnostic Drugs Market Share by Region (2025-2030)
Table 14. Radioactive Diagnostic Drugs Market Trends
Table 15. Radioactive Diagnostic Drugs Market Drivers
Table 16. Radioactive Diagnostic Drugs Market Challenges
Table 17. Radioactive Diagnostic Drugs Market Restraints
Table 18. Global Radioactive Diagnostic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Radioactive Diagnostic Drugs Market Share by Players (2019-2024)
Table 20. Global Top Radioactive Diagnostic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Diagnostic Drugs as of 2023)
Table 21. Ranking of Global Top Radioactive Diagnostic Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Radioactive Diagnostic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Radioactive Diagnostic Drugs Product Solution and Service
Table 25. Date of Enter into Radioactive Diagnostic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Radioactive Diagnostic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Radioactive Diagnostic Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Radioactive Diagnostic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Radioactive Diagnostic Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Radioactive Diagnostic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Radioactive Diagnostic Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Radioactive Diagnostic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Radioactive Diagnostic Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Radioactive Diagnostic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Curium Company Detail
Table 51. Curium Business Overview
Table 52. Curium Radioactive Diagnostic Drugs Product
Table 53. Curium Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 54. Curium Recent Development
Table 55. Medi-Radiopharma Company Detail
Table 56. Medi-Radiopharma Business Overview
Table 57. Medi-Radiopharma Radioactive Diagnostic Drugs Product
Table 58. Medi-Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 59. Medi-Radiopharma Recent Development
Table 60. Jubilant Radiopharma Company Detail
Table 61. Jubilant Radiopharma Business Overview
Table 62. Jubilant Radiopharma Radioactive Diagnostic Drugs Product
Table 63. Jubilant Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 64. Jubilant Radiopharma Recent Development
Table 65. Telix Company Detail
Table 66. Telix Business Overview
Table 67. Telix Radioactive Diagnostic Drugs Product
Table 68. Telix Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 69. Telix Recent Development
Table 70. Mallinckrodt Company Detail
Table 71. Mallinckrodt Business Overview
Table 72. Mallinckrodt Radioactive Diagnostic Drugs Product
Table 73. Mallinckrodt Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 74. Mallinckrodt Recent Development
Table 75. Cardinal Health Company Detail
Table 76. Cardinal Health Business Overview
Table 77. Cardinal Health Radioactive Diagnostic Drugs Product
Table 78. Cardinal Health Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 79. Cardinal Health Recent Development
Table 80. Bayer AG Company Detail
Table 81. Bayer AG Business Overview
Table 82. Bayer AG Radioactive Diagnostic Drugs Product
Table 83. Bayer AG Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 84. Bayer AG Recent Development
Table 85. GE Healthcare Company Detail
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Radioactive Diagnostic Drugs Product
Table 88. GE Healthcare Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 89. GE Healthcare Recent Development
Table 90. Mallinckrodt Pharmaceuticals Company Detail
Table 91. Mallinckrodt Pharmaceuticals Business Overview
Table 92. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product
Table 93. Mallinckrodt Pharmaceuticals Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 94. Mallinckrodt Pharmaceuticals Recent Development
Table 95. Bracco Group Company Detail
Table 96. Bracco Group Business Overview
Table 97. Bracco Group Radioactive Diagnostic Drugs Product
Table 98. Bracco Group Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 99. Bracco Group Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioactive Diagnostic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Radioactive Diagnostic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Single Photon Drugs Features
Figure 4. Positron Drugs Features
Figure 5. Blood Perfusion Drugs Features
Figure 6. Metabolizing Drugs Features
Figure 7. Receptor Binding Drugs Features
Figure 8. Others Features
Figure 9. Global Radioactive Diagnostic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Radioactive Diagnostic Drugs Market Share by Application: 2023 VS 2030
Figure 11. Oncology Case Studies
Figure 12. Cardiology Case Studies
Figure 13. Neuroscience Case Studies
Figure 14. Thyroid Case Studies
Figure 15. Others Case Studies
Figure 16. Radioactive Diagnostic Drugs Report Years Considered
Figure 17. Global Radioactive Diagnostic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Radioactive Diagnostic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Radioactive Diagnostic Drugs Market Share by Region: 2023 VS 2030
Figure 20. Global Radioactive Diagnostic Drugs Market Share by Players in 2023
Figure 21. Global Top Radioactive Diagnostic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Diagnostic Drugs as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Radioactive Diagnostic Drugs Revenue in 2023
Figure 23. North America Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 25. United States Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 29. Germany Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Radioactive Diagnostic Drugs Market Share by Region (2019-2030)
Figure 37. China Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 45. Mexico Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 49. Turkey Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Curium Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 52. Medi-Radiopharma Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 53. Jubilant Radiopharma Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 54. Telix Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 55. Mallinckrodt Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 56. Cardinal Health Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 57. Bayer AG Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 58. GE Healthcare Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 59. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 60. Bracco Group Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Radioactive Diagnostic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Single Photon Drugs
Table 3. Key Players of Positron Drugs
Table 4. Key Players of Blood Perfusion Drugs
Table 5. Key Players of Metabolizing Drugs
Table 6. Key Players of Receptor Binding Drugs
Table 7. Key Players of Others
Table 8. Global Radioactive Diagnostic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Radioactive Diagnostic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Radioactive Diagnostic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Radioactive Diagnostic Drugs Market Share by Region (2019-2024)
Table 12. Global Radioactive Diagnostic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Radioactive Diagnostic Drugs Market Share by Region (2025-2030)
Table 14. Radioactive Diagnostic Drugs Market Trends
Table 15. Radioactive Diagnostic Drugs Market Drivers
Table 16. Radioactive Diagnostic Drugs Market Challenges
Table 17. Radioactive Diagnostic Drugs Market Restraints
Table 18. Global Radioactive Diagnostic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Radioactive Diagnostic Drugs Market Share by Players (2019-2024)
Table 20. Global Top Radioactive Diagnostic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Diagnostic Drugs as of 2023)
Table 21. Ranking of Global Top Radioactive Diagnostic Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Radioactive Diagnostic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Radioactive Diagnostic Drugs Product Solution and Service
Table 25. Date of Enter into Radioactive Diagnostic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Radioactive Diagnostic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Radioactive Diagnostic Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Radioactive Diagnostic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Radioactive Diagnostic Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Radioactive Diagnostic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Radioactive Diagnostic Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Radioactive Diagnostic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Radioactive Diagnostic Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Radioactive Diagnostic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Radioactive Diagnostic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Curium Company Detail
Table 51. Curium Business Overview
Table 52. Curium Radioactive Diagnostic Drugs Product
Table 53. Curium Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 54. Curium Recent Development
Table 55. Medi-Radiopharma Company Detail
Table 56. Medi-Radiopharma Business Overview
Table 57. Medi-Radiopharma Radioactive Diagnostic Drugs Product
Table 58. Medi-Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 59. Medi-Radiopharma Recent Development
Table 60. Jubilant Radiopharma Company Detail
Table 61. Jubilant Radiopharma Business Overview
Table 62. Jubilant Radiopharma Radioactive Diagnostic Drugs Product
Table 63. Jubilant Radiopharma Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 64. Jubilant Radiopharma Recent Development
Table 65. Telix Company Detail
Table 66. Telix Business Overview
Table 67. Telix Radioactive Diagnostic Drugs Product
Table 68. Telix Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 69. Telix Recent Development
Table 70. Mallinckrodt Company Detail
Table 71. Mallinckrodt Business Overview
Table 72. Mallinckrodt Radioactive Diagnostic Drugs Product
Table 73. Mallinckrodt Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 74. Mallinckrodt Recent Development
Table 75. Cardinal Health Company Detail
Table 76. Cardinal Health Business Overview
Table 77. Cardinal Health Radioactive Diagnostic Drugs Product
Table 78. Cardinal Health Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 79. Cardinal Health Recent Development
Table 80. Bayer AG Company Detail
Table 81. Bayer AG Business Overview
Table 82. Bayer AG Radioactive Diagnostic Drugs Product
Table 83. Bayer AG Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 84. Bayer AG Recent Development
Table 85. GE Healthcare Company Detail
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Radioactive Diagnostic Drugs Product
Table 88. GE Healthcare Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 89. GE Healthcare Recent Development
Table 90. Mallinckrodt Pharmaceuticals Company Detail
Table 91. Mallinckrodt Pharmaceuticals Business Overview
Table 92. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product
Table 93. Mallinckrodt Pharmaceuticals Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 94. Mallinckrodt Pharmaceuticals Recent Development
Table 95. Bracco Group Company Detail
Table 96. Bracco Group Business Overview
Table 97. Bracco Group Radioactive Diagnostic Drugs Product
Table 98. Bracco Group Revenue in Radioactive Diagnostic Drugs Business (2019-2024) & (US$ Million)
Table 99. Bracco Group Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioactive Diagnostic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Radioactive Diagnostic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Single Photon Drugs Features
Figure 4. Positron Drugs Features
Figure 5. Blood Perfusion Drugs Features
Figure 6. Metabolizing Drugs Features
Figure 7. Receptor Binding Drugs Features
Figure 8. Others Features
Figure 9. Global Radioactive Diagnostic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Radioactive Diagnostic Drugs Market Share by Application: 2023 VS 2030
Figure 11. Oncology Case Studies
Figure 12. Cardiology Case Studies
Figure 13. Neuroscience Case Studies
Figure 14. Thyroid Case Studies
Figure 15. Others Case Studies
Figure 16. Radioactive Diagnostic Drugs Report Years Considered
Figure 17. Global Radioactive Diagnostic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Radioactive Diagnostic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Radioactive Diagnostic Drugs Market Share by Region: 2023 VS 2030
Figure 20. Global Radioactive Diagnostic Drugs Market Share by Players in 2023
Figure 21. Global Top Radioactive Diagnostic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Diagnostic Drugs as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Radioactive Diagnostic Drugs Revenue in 2023
Figure 23. North America Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 25. United States Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 29. Germany Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Radioactive Diagnostic Drugs Market Share by Region (2019-2030)
Figure 37. China Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 45. Mexico Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Radioactive Diagnostic Drugs Market Share by Country (2019-2030)
Figure 49. Turkey Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Radioactive Diagnostic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Curium Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 52. Medi-Radiopharma Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 53. Jubilant Radiopharma Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 54. Telix Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 55. Mallinckrodt Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 56. Cardinal Health Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 57. Bayer AG Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 58. GE Healthcare Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 59. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 60. Bracco Group Revenue Growth Rate in Radioactive Diagnostic Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232